Wilson Stepping Down
James Wilson, director of the Institute for Human Gene Therapy
since it was founded in 1992, will step down as director July
1. He will dedicate more of his time to "teaching and research
in the development of novel gene delivery vehicles and their application
in the treatment of diabetes, cystic fibrosis and infectious diseases."
Arthur Rubenstein announced that he has accepted the findings
and recommendations of the eight-member faculty committee which
was charged in August 2001 with reviewing IHGT's focus as well
as the state of gene therapy research. They recommended that IHGT
broaden its scientific focus to include cell-based therapies,
as well as stem cell biology and molecular virology.
Almanac, Vol. 48, No. 31, April 23, 2002
April 23, 2002
Volume 48 Number 31